Letter to the editor

DOI: 10.4244/EIJ-D-23-00830

Letter: Due to the lack of significant mortality benefit along with high procedural complication rates, percutaneous coronary intervention of chronic total occlusions should be discouraged

Mohammad Reza Movahed1, MD, PhD

With great interest, I read the manuscript entitled “Three-year Outcomes of A Randomised Multicenter Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions (EuroCTO)” in EuroIntervention1. They confirmed numerous previous data that chronic total occlusion (CTO) interventions do not improve clinically significant outcomes, myocardial infarction or mortality. However, the authors overstated the benefit of a CTO intervention by stating that CTO percutaneous coronary intervention (PCI) appears to be a safe option for patients with a single remaining significant coronary CTO. The authors completely downplayed numerous trials showing very high complication rates in patients undergoing CTO PCI in comparison to other lesions23. We recently published the largest data regarding CTO PCI confirming much higher in-patient mortality and complications in this population4. A weighted total of 259,574 patients underwent CTO PCI. The CTO patients had a 3.17% mortality rate versus 2.57% for non-CTO PCIs (odds ratio [OR] 1.24), which remained significant despite adjusting for numerous baseline and clinical characteristics. Furthermore, patients with CTO were compared with non-CTO PCI, showing much higher rates of myocardial infarction (OR 2.85), coronary perforation (OR 6.01), tamponade (OR 3.36), contrast-induced nephropathy (OR 2.05), procedural bleeding (OR 3.57), and acute postprocedural respiratory failure (OR 2.07). The total postprocedural complications for CTO patients were more than 3 times those of non-CTO patients (OR 3.45). In concordance with our conclusion, Allahwala et al5 agree that CTO PCI should not be performed unless the patient has severe resistant angina and for symptom release only. However, CTO PCI is too often performed without informing the patient that this dangerous procedure will not prolong life. It is time to have a better oversight of interventionalists who perform too many unnecessary PCIs of CTO6.

Conflict of interest statement

M.R. Movahed has no conflicts of interest to declare.


References

Volume 20 Number 1
Jan 1, 2024
Volume 20 Number 1
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-23-00040 Sep 18, 2023
Reconsidering the evidence for CTO PCI: the devil is in the detail
Al-Lamee R et al
free

10.4244/EIJV12I11A218 Dec 9, 2016
Conquering CTO revascularisation: the summit is near with 90% of the ascent behind us
Di Mario C and Dini C
free

Research correspondence

10.4244/EIJ-D-22-00599 Dec 2, 2022
In-hospital outcomes and temporal trends of percutaneous coronary interventions for chronic total occlusion
Kostantinis S et al
free
Trending articles
309.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
166.7

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
92.2

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
76

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
72.85

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
58.3

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
33.9

CLINICAL RESEARCH

10.4244/EIJ-D-17-00381 Oct 11, 2017
Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model
Foin N et al
free
33.65

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved